Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
138,961,039
-
Total 13F shares
-
6,172,248
-
Share change
-
+892,031
-
Total reported value
-
$11,665,159
-
Put/Call ratio
-
14%
-
Price per share
-
$1.89
-
Number of holders
-
67
-
Value change
-
+$790,503
-
Number of buys
-
36
-
Number of sells
-
22
Institutional Holders of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) as of Q4 2023
As of 31 Dec 2023,
Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,172,248 shares.
The largest 10 holders included
VANGUARD GROUP INC, GMT CAPITAL CORP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, D. E. Shaw & Co., Inc., and STATE STREET CORP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.